论文信息 - Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium - 字舞流文

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

S. Groshen | J. Maris | K. Matthay | H. Shimada | D. Haas-Kogan | Y. Mossé | Lingyun Ji | S. Cohn | J. Villablanca | G. Yanik | S. Shusterman | F. Goodarzian | Julie R. Park | S. DuBois | M. Irwin | D. Tsao-Wei | M. Granger | Anasheh Shamirian | S. Czarnecki | R. Berkovich | Kieuhoa T Vo | Navin Pinto | K. Goldsmith | B. Weiss | C. Twist | A. Marachelian | N. Pinto | K. Vo